Literature DB >> 27862882

Contraceptive method preferences and provision after termination of pregnancy: a population-based analysis of women obtaining care with the British Pregnancy Advisory Service.

Ara Aiken1,2, P A Lohr3, C E Aiken4, T Forsyth3, J Trussell5,6.   

Abstract

OBJECTIVE: To examine contraceptive choices among women seeking termination of pregnancy (TOP) and the provision of the chosen methods.
DESIGN: Population-based study.
SETTING: British Pregnancy Advisory Service (BPAS) clinics in England and Wales. POPULATION: Between 1 January 2011 and 31 December 2014, 211 215 women had a TOP at BPAS, were offered contraceptive counselling, and were eligible to obtain contraception at no cost.
METHODS: We examined electronic records from BPAS and assessed the proportions of women who accepted contraceptive counselling and chose a contraceptive method, as well as the distributions of methods chosen, analysed by provider and by TOP type. We calculated the proportions receiving their chosen method and the methods chosen by women using no method at conception. We used logistic regression to examine the factors associated with choice of an intrauterine contraceptive (IUC) or implant. MAIN OUTCOME MEASURES: Post-TOP contraceptive method choice. Receipt of chosen method post-TOP.
RESULTS: Eighty-five per cent of women accepted contraceptive counselling and 51% chose to obtain a method from BPAS rather than from a GP or contraception and sexual health clinic post-TOP. [correction added on 25 November 2016 after first online publication: 51% has been inserted in the preceding sentence.] Among those who wanted to receive contraception from BPAS, 51% chose an IUC or implant and 19% chose oral contraceptives. Ninety-one per cent of women who obtained contraception from BPAS received their chosen method. Women were more likely to choose an IUC or implant if they obtained contraception from BPAS, had a surgical TOP, were parous, young, white, or had one or more previous TOPs.
CONCLUSIONS: The standards set for patient-centred TOP care should emphasise the need for a full range of contraceptive options to be offered and provided post-TOP. TWEETABLE ABSTRACT: Uptake targets for long-acting reversible methods do not reflect women's post-TOP contraceptive preferences.
© 2016 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Contraceptive counselling; contraceptive preferences; contraceptive service provision; post-TOP contraception

Mesh:

Year:  2016        PMID: 27862882      PMCID: PMC5506553          DOI: 10.1111/1471-0528.14413

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  28 in total

1.  Specialist contraceptive counselling and provision after termination of pregnancy improves uptake of long-acting methods but does not prevent repeat abortion: a randomized trial.

Authors:  C Schunmann; Anna Glasier
Journal:  Hum Reprod       Date:  2006-06-03       Impact factor: 6.918

2.  Impact of long-acting reversible contraception on return for repeat abortion.

Authors:  Sally B Rose; Beverley A Lawton
Journal:  Am J Obstet Gynecol       Date:  2011-07-13       Impact factor: 8.661

3.  Unplanned pregnancy and contraceptive use in Hull and East Yorkshire.

Authors:  Helen Bexhell; Kate Guthrie; Kelly Cleland; James Trussell
Journal:  Contraception       Date:  2015-10-28       Impact factor: 3.375

4.  Preventing unintended pregnancies by providing no-cost contraception.

Authors:  Jeffrey F Peipert; Tessa Madden; Jenifer E Allsworth; Gina M Secura
Journal:  Obstet Gynecol       Date:  2012-12       Impact factor: 7.661

5.  Provision of no-cost, long-acting contraception and teenage pregnancy.

Authors:  Gina M Secura; Tessa Madden; Colleen McNicholas; Jennifer Mullersman; Christina M Buckel; Qiuhong Zhao; Jeffrey F Peipert
Journal:  N Engl J Med       Date:  2014-10-02       Impact factor: 91.245

6.  Celebration meets caution: LARC's boons, potential busts, and the benefits of a reproductive justice approach.

Authors:  Jenny A Higgins
Journal:  Contraception       Date:  2014-02-10       Impact factor: 3.375

7.  Global fee prohibits postpartum provision of the most effective reversible contraceptives.

Authors:  Abigail R A Aiken; Mitchell D Creinin; Andrew M Kaunitz; Anita L Nelson; James Trussell
Journal:  Contraception       Date:  2014-08-07       Impact factor: 3.375

8.  Understanding women's desires for contraceptive counseling at the time of first-trimester surgical abortion.

Authors:  Melissa Matulich; Catherine Cansino; Kelly R Culwell; Mitchell D Creinin
Journal:  Contraception       Date:  2013-09-30       Impact factor: 3.375

9.  Barriers to Postpartum Contraception in Texas and Pregnancy Within 2 Years of Delivery.

Authors:  Joseph E Potter; Celia Hubert; Amanda Jean Stevenson; Kristine Hopkins; Abigail R A Aiken; Kari White; Daniel Grossman
Journal:  Obstet Gynecol       Date:  2016-02       Impact factor: 7.623

10.  Associations Between Abortion Services and Acceptance of Postabortion Contraception in Six Indian States.

Authors:  Sushanta K Banerjee; Sumit Gulati; Kathryn L Andersen; Valerie Acre; Janardan Warvadekar; Deepa Navin
Journal:  Stud Fam Plann       Date:  2015-12
View more
  3 in total

1.  Telephone or integrated contraception counselling before abortion: impact on method choice and receipt.

Authors:  Patricia A Lohr; Abigail R A Aiken; Tracey Forsyth; James Trussell
Journal:  BMJ Sex Reprod Health       Date:  2018-02-03

2.  Specialist follow-up contraceptive support after abortion-Impact on effective contraceptive use at six months and subsequent abortions: A randomised controlled trial.

Authors:  Usha Kumar; Louise Pollard; Lucy Campbell; Selin Yurdakul; Clara Cantalapiedra Calvete; Bola Coker; Tao Chen; Abdel Douiri
Journal:  PLoS One       Date:  2019-06-11       Impact factor: 3.240

3.  Abortion care pathways and service provision for adolescents in high-income countries: A qualitative synthesis of the evidence.

Authors:  Anisa R Assifi; Melissa Kang; Elizabeth A Sullivan; Angela J Dawson
Journal:  PLoS One       Date:  2020-11-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.